Tejal Shah

Tejal Shah is Global Regulatory Affairs Manager, GSK.

  • ECCP-Main

    The worldwide acceptance of non-legalised eCPPs


    The transition from paper-based format to electronic Certificates of Pharmaceutical Product (eCPPs) has seen an increased uptake as a result of the operational limitations associated with the COVID-19 pandemic. While issuing regulatory agencies (RA), such the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) now offer ...